167 related articles for article (PubMed ID: 20659940)
21. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
22. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
Daniels G; Finning K; Martin P; Soothill P
Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
[TBL] [Abstract][Full Text] [Related]
23. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
Hawk AF; Chang EY; Shields SM; Simpson KN
Obstet Gynecol; 2013 Sep; 122(3):579-85. PubMed ID: 23921866
[TBL] [Abstract][Full Text] [Related]
24. RhD hemolytic disease of the newborn.
Bowman JM
N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
[No Abstract] [Full Text] [Related]
25. The detection of anti-D in Rho (D)-negative infants born of Rho (D)-positive mothers.
Bowen FW; Renfield M
Pediatr Res; 1976 Apr; 10(4):213-5. PubMed ID: 818607
[TBL] [Abstract][Full Text] [Related]
26. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
[TBL] [Abstract][Full Text] [Related]
27. Transfusion support in the management of immune haemolytic disorders.
Plapp FV; Beck ML
Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
[No Abstract] [Full Text] [Related]
28. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience.
Pereira JC; Couceiro AB; Cunha EM; Machado AI; Tamagnini GP; Martins NP; Ribeiro ML
Prenat Diagn; 2007 Jul; 27(7):633-7. PubMed ID: 17497744
[TBL] [Abstract][Full Text] [Related]
29. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
30. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
31. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
Lee D
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
[No Abstract] [Full Text] [Related]
32. An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside.
Rennie I; Smith A; Smith R; Rawlinson PS; Clark P
Health Bull (Edinb); 2001 May; 59(3):150-4. PubMed ID: 12664753
[TBL] [Abstract][Full Text] [Related]
33. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
34. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
[TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
[TBL] [Abstract][Full Text] [Related]
36. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
37. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
Sainio S; Kuosmanen M
Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
[TBL] [Abstract][Full Text] [Related]
38. Can serological methods help distinguish between prophylactic and alloimmune anti-D?
Irving C; Crennan M; Vanniasinkam T
Transfus Med; 2017 Oct; 27 Suppl 5():362-368. PubMed ID: 28508562
[TBL] [Abstract][Full Text] [Related]
39. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing hemolytic disease of the newborn.
Brantley TA
Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
